Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Certara, Inc. - Common Stock
(NQ:
CERT
)
4.585
+0.105 (+2.34%)
Streaming Delayed Price
Updated: 3:44 PM EDT, May 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Markets Reel As Trump's Tariffs Hit — Magnificent 7 Set To Shed Almost $700 Billion
↗
April 02, 2025
Trump's new tariffs trigger selloff, framed as correction to trade imbalance. China faces 37% duties, EU 20%, Japan 24%. Tech stocks hit hard.
Via
Benzinga
Topics
Government
World Trade
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 01, 2025
Updates strengthen Certara’s position as a leader of PBPK modeling in drug development to advance regulatory decision-making
From
Certara
Via
GlobeNewswire
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Certara
↗
November 07, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
↗
October 15, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
↗
September 27, 2024
Via
Benzinga
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
March 05, 2025
McKemey joins Certara to accelerate growth of its strategic drug development solutions
From
Certara
Via
GlobeNewswire
Certara Reports Fourth Quarter 2024 Financial Results
February 26, 2025
Issues Full Year 2025 Financial Guidance
From
Certara
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 14, 2025
Via
Benzinga
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
January 29, 2025
From
Certara
Via
GlobeNewswire
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
From
Certara
Via
GlobeNewswire
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From
Certara
Via
GlobeNewswire
Certara Showcases 2024 Research Wins With Over 100 Papers Published
December 02, 2024
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2024 Financial Results
November 06, 2024
Updates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
From
Certara
Via
GlobeNewswire
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From
MaxCyte, Inc
Via
GlobeNewswire
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
October 09, 2024
From
Certara
Via
GlobeNewswire
Certara Completes Acquisition of Chemaxon
October 02, 2024
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through...
From
Certara
Via
GlobeNewswire
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
↗
September 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 27, 2024
Via
Benzinga
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024
The pre-competitive scientific research consortium of top pharmaceutical companies remains a critical force in advancing qualified PBPK modeling and simulation to further drug development and...
From
Certara
Via
GlobeNewswire
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024
Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to select a higher starting dose that would lower costs and reduce cycle times
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
↗
August 06, 2024
CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From
Certara
Via
GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From
Certara
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
